Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Alberta
$27,000.00
Avascular Meniscus Repair Using Migratory Meniscus Cells
EF 2025-26
Résumé
Avascular meniscus injuries, which do not heal naturally, are a significant risk factor for early knee osteoarthritis. Human meniscus fibrochondrocytes (MFC) are responsible for producing the biomechanically functional components of the meniscus, and their migratory capacity is critical for tissue repair. This study aims to develop a migratory MFC population derived from porcine menisci as a preclinical model to explore their potential in repairing avascular meniscal injuries. The first objective is to characterize migratory MFC using single-cell RNA sequencing (scRNAseq). Pig menisci will be sourced, and MFC will be isolated and amplified. The cells will undergo scRNAseq using Parse Biosciences' Evercode Whole Transcriptome kits, and sequencing will be performed on an Illumina NextSeq 500 platform. This analysis will identify molecular profiles and cell surface markers associated with tissue repair. The second objective is to evaluate the potential of migratory MFC to repair avascular meniscus injury in a Yucatan pig model. Autologous MFC microtissues, both preselected based on the criteria from Objective 1 and unselected, will be seeded on scaffolds and implanted into surgically created meniscal defects. The pigs will undergo MRI assessments at 1, 3, and 6 months post-operation to monitor healing, with histological and molecular analyses performed at study completion. We hypothesize that preselected MFC will show superior healing compared to unselected controls. Should preselected MFC fail to promote optimal healing, further cloning and selection of promising MFC populations will be pursued.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572732
Name
Ekundayo Oladapo O
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Avascular Meniscus Repair Using Migratory Meniscus Cells
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Avascular Meniscus Repair; Extracellular Matrix; Large Animal Study; Meniscus; Meniscus Fibrochondrocytes; Migratory Fibrochondrocytes; Outgrowth Cells; Porous Scaffolds; Rna Sequencing; Tissue Engineering
Abstract
Avascular meniscus injuries, which do not heal naturally, are a significant risk factor for early knee osteoarthritis. Human meniscus fibrochondrocytes (MFC) are responsible for producing the biomechanically functional components of the meniscus, and their migratory capacity is critical for tissue repair. This study aims to develop a migratory MFC population derived from porcine menisci as a preclinical model to explore their potential in repairing avascular meniscal injuries. The first objective is to characterize migratory MFC using single-cell RNA sequencing (scRNAseq). Pig menisci will be sourced, and MFC will be isolated and amplified. The cells will undergo scRNAseq using Parse Biosciences' Evercode Whole Transcriptome kits, and sequencing will be performed on an Illumina NextSeq 500 platform. This analysis will identify molecular profiles and cell surface markers associated with tissue repair. The second objective is to evaluate the potential of migratory MFC to repair avascular meniscus injury in a Yucatan pig model. Autologous MFC microtissues, both preselected based on the criteria from Objective 1 and unselected, will be seeded on scaffolds and implanted into surgically created meniscal defects. The pigs will undergo MRI assessments at 1, 3, and 6 months post-operation to monitor healing, with histological and molecular analyses performed at study completion. We hypothesize that preselected MFC will show superior healing compared to unselected controls. Should preselected MFC fail to promote optimal healing, further cloning and selection of promising MFC populations will be pursued.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ekundayo, Oladapo O
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~